Skip to main content
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 2005 May;140(2):394. doi: 10.1111/j.1365-2249.2005.02769.x

Erratum

PMCID: PMC1809365

In [1], the link to the supplementary table, Table S1, was erroneously omitted. Table S1 is printed below.

Table S1.

Description of patients

Patient* no. Age Disease severity Mutation Splenectomy IVG**
Infants  1  1 month Severe G431 > A; E133K
 2  2 Severe G252 > A; C73Y
 3  3 Severe G431 > A; E133K + +
 4  5 Mild G257 > A; V75M
 5  6 Severe C71 > T; R13X
 6  9 Severe Large deletion, no mRNA + n.a.
 7 12 Severe IVS8 + 1 g > c; donor site
 8 13 Mild 476–7insA; fs R148, X168
 9 16 n.a. 254–5insGGCT; fs F74, X78 n.a. n.a.
10 18 Severe G185 > T; V51F
11 22 Mild IVS6–1 g > a, acceptor site
12 24 Moderate/severe 1055–6insT; fs P341, X495 +
13 25 Severe IVS8 + 1 g > a donor site +
Children 14  4 years Mild C201 > T; A56V
15  5 Mild IVS 6 + 5 g > a, donor site +
16  6 Mild C1124 > T; R364X
17  7 Mild C168 > T; T45M +
18  8 Mild 476–7insA; fs R148, X168
19 12 Moderate G1487 > A; D485 > N +
20 12 Severe IVS8 + 1 g > a; donor site + +
21 13 Severe 41–42del TT; X37 + n.a.
22 13 Moderate G1487 > A; D485 > N +
23 14 Mild G291 > A; R86H + +
24 15 Moderate G325 > C; W97C +
25 16 Moderate G291 > A; R86H + +
Adults 26 22 years Moderate G1305 delete; fs G424, X444 + +
27 24 Moderate G1305 delete; fs G424, X444 + +
28 42 Moderate IVS 6 + 5 g > a, donor site –/+
29 50 Severe C947 > T; Q305X +
30 54 Mild C168 > T; T45M + ¯
*

Patient mutations are reported in [16] and Lutskiy et al. (in preparation).

**

IVG, intravenous gammaglobulin therapy; n.a., information not available.

We apologize for this error.

References

  • 1.Park JY, Shcherbina A, Rosen FS, Prodeus AP, Remold-O’Donnell E. Phenotypic perturbation of B cells in the Wiskott–Aldrich syndrome. Clin Exp Immunol. 2005;139:297–305. doi: 10.1111/j.1365-2249.2005.02693.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES